CIA-Linked Investor Helped Quantum Systems Expand in US 
Mercer International Stock Surges 45% on C$20 Million Canada Funding 
Google Changes EU Spam Policy Amid Antitrust Scrutiny 
BofA Names ASML Top Semiconductor Equipment Pick on Growth, Valuation 
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition 
BNP Paribas, KB Kookmin Eye $2 Billion Techcombank Stake 
Pinterest Stock Falls as CFO Julia Brau Donnelly Resigns 
Nvidia Pauses AI Cloud Financing Deals Amid Antitrust Concerns 
OpenAI AI Agent Swarm Behind Hugging Face Hack 
Trump Administration Plans New Drug Pricing Deals With Biotech Firms 
Street Poller Media and The Boom of the Street Interview Ad Industry 
Meta Agrees to $18 Billion Settlement, Tightens Teen Social Media Rules 
PayPal Shares Sink as $50 Billion Takeover Bid Collapses 
Star Entertainment Shares Fall After A$307 Million FY2026 Loss 
GM Canada Workers Approve C$1.1 Billion Investment Deal 
Jefferies Names AMEC Top China Semiconductor Equipment Pick 
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China 
Add as a preferred source on Google
ISELIN, N.J., April 02, 2018 -- UBM Life Sciences Group’s Pharmaceutical Executive today opened nominations for Emerging Pharma Leaders, an awards program that for 10 years has recognized and honored up-and-coming professionals who are vital to the future of the pharmaceutical and biotech industry.
“It’s time again for us to ask, ‘Are you, or is your colleague, a leader in pharma?’” said Lisa Henderson, editor-in-chief of Pharmaceutical Executive. “Every year, nominees and winners find ways to inspire us. It's exciting to highlight their unique skills and qualities.”
Nominations of professionals employed by pharmaceutical or biotech companies will be judged by members of Pharmaceutical Executive’s editorial advisory board, and an Emerging Pharma Leaders alumnus.
“Emerging Pharma Leaders live and work across the world, but all share key qualities,” continued Henderson. “They show willingness to grow. They have the ability to listen. They learn from their mentors, and bring a special enthusiasm to lead their staff and share the load.”
Pharmaceutical Executive will accept nominations through June 30, 2018, reveal this year's winners through a special feature in its October issue, and celebrate their accomplishments with other industry leaders at a special, in-person event in November.
For more information, visit pharmexec.com/leaders2018.
About UBM Americas' Life Sciences Group
UBM Life Sciences is a US-based event, information, and marketing services business serving professional communities in human healthcare, veterinary medicine, and the pharmaceutical industry with an unmatched portfolio of in-person, print, and digital products. The business includes 4 trade shows, over 100 conferences, 30 publications, and over 100 digital products and websites. Reaching over 2 million life sciences professionals monthly, UBM Life Sciences enables the professional communities it serves to learn, connect, and conduct business. UBM Life Sciences is a business unit of UBM Americas, a division of UBM plc.
About UBM plc
UBM plc is the largest pure-play B2B Events organiser in the world. In an increasingly digital world, the value of connecting on a meaningful, human level has never been more important. At UBM, our deep knowledge and passion for the industry sectors we serve allow us to create valuable experiences where people can succeed. At our events people build relationships, close deals and grow their businesses.
Our 3,750+ people, based in more than 20 countries, serve more than 50 different industry sectors—from fashion to pharmaceutical ingredients. These global networks, skilled, passionate people and market-leading events provide exciting opportunities for business people to achieve their ambitions.
For more information, go to www.ubm.com; for UBM corporate news, follow us on Twitter at @UBM.
Media Contacts: UBM Americas - Life Sciences Group Amy Erdman Vice President, Marketing [email protected] (203) 523-7041
